Skip to main content
Caplight Logo









Nectar

Nectar

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.mynectar.com/

Last Round

Series A

Dec 20, 2022

Total Funding Raised

$24.5M

Company Overview

Nectar is a healthtech company that provides a comprehensive, vertically integrated allergy healthcare platform offering personalized, patient-centric allergy care.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Precision Medicine, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Non-AI

Keywords

allergy dropssublingual immunotherapyat-home allergy testallergy caredirect-to-consumerD2Ctelehealthtelemedicinedigital healthhybrid care modelhealth techprecision medicinesubscription commerceasthma treatmenteczema treatmentcompounding pharmacypediatric allergy care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nectar Comparables

Compare Nectar with similar companies based on industry and business-model similarity.

Nectar comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wyndly
94%
Curex
93%
Allermi
78%

Nectar Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 20, 2022
SeedMar 17, 2022

Key People

Founding team and executive leadership

Michael Tanoury

Chief Executive Officer

Executive Team

Tsega Dinka

Chief Product and Growth Officer

Executive Team

Nectar Investors

Notable investors and investment history

Nectar investors
InvestorRounds
JuxtaposeSeries A, Seed
Obvious VenturesSeries A, Seed
Harmony PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors grew 117% MoM, reaching 61.5K.

  • Dec 20, 2022

    $17M round led by Harmony Partners.

Nectar Filings

Explore SEC and related filing metadata, where available.

Nectar filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nectar's valuation, stock price, and market status.

Is Nectar a public or private company?

Nectar is a private company.

What is the current stock price of Nectar?

Nectar is a private company with no public stock price. No recent secondary market data is available.

How much is Nectar worth (valuation)?

Valuation information for Nectar is not publicly available.

Can I buy Nectar stock?

Nectar shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nectar's last funding round?

Nectar's most recent funding round was Series A on December 20, 2022.

Who are the main investors in Nectar?

Key investors in Nectar include Juxtapose, Obvious Ventures, Harmony Partners.

Will Nectar IPO soon?

No public IPO plans have been announced for Nectar.

How can I track Nectar secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nectar's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range17
Year Founded2021
Last FundingDec 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?